![Pathologic classification of focal segmental glomerulosclerosis: a working proposal - American Journal of Kidney Diseases Pathologic classification of focal segmental glomerulosclerosis: a working proposal - American Journal of Kidney Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3cf74f4b-9f50-48ee-aaff-aa93670b54b8/gr1_lrg.jpg)
Pathologic classification of focal segmental glomerulosclerosis: a working proposal - American Journal of Kidney Diseases
![Novel parietal epithelial cell subpopulations contribute to focal segmental glomerulosclerosis and glomerular tip lesions - Kidney International Novel parietal epithelial cell subpopulations contribute to focal segmental glomerulosclerosis and glomerular tip lesions - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d8cceef0-6921-4881-9198-e2f184670133/fx1.jpg)
Novel parietal epithelial cell subpopulations contribute to focal segmental glomerulosclerosis and glomerular tip lesions - Kidney International
PLOS ONE: Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis
![Focal Segmental Glomerulosclerosis Market 2021 Top 10 Global Players Introducing Future Opportunities and Demand by 2027 – GlaxoSmithKline plc., Novartis AG, AbbVie, Inc., Pfizer, Inc., Sanofi S.A | Medgadget Focal Segmental Glomerulosclerosis Market 2021 Top 10 Global Players Introducing Future Opportunities and Demand by 2027 – GlaxoSmithKline plc., Novartis AG, AbbVie, Inc., Pfizer, Inc., Sanofi S.A | Medgadget](https://www.medgadget.com/wp-content/uploads/2021/10/focal-segmental-glomerulosclerosis-market.jpg)